This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gorgievski-Hrisoho, M Articles by Siegl, G Search for Related Content PubMed PubMed Citation Articles by Gorgievski-Hrisoho, M Articles by Siegl, G

 Previous Article  |  Next Article 

J Clin Microbiol. 1990 October; 28(10): 2305-2311

Serodiagnosis of infectious mononucleosis by using recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology.

Division of Virology, Institute for Medical Microbiology, University of Bern, Switzerland.

ABSTRACT

Four recombinant, diagnostically useful Epstein-Barr virus (EBV) proteins representative of the viral capsid antigen (p150), diffuse early antigen (p54), the major DNA-binding protein (p138), and the EBV nuclear antigen (p72) (W. Hinderer, H. Nebel-Schickel, H.H. Sonneborn, M. Motz, R. Kühbeck, and H. Wolf, J. Exp. Clin. Cancer Res. 7[Suppl.]:132, 1988) were used to set up individual enzyme-linked immunosorbent assays (ELISAs) for the qualitative and quantitative detection of immunoglobulin M (IgM) and IgG antibodies. In direct comparison with results obtained by standard immunofluorescence or immunoperoxidase assays, it was then shown that the recombinant EBV ELISAs provide the means for specific and sensitive serodiagnosis of infectious mononucleosis (IM) caused by EBV. The most useful markers in sera from such patients proved to be IgM antibodies against p54, p138, and p150. Additional positive markers for recent or ongoing IM apparently were IgG antibodies against p54 and p138. In contrast, anti-p72 IgG had a high preference for sera from healthy blood donors and, therefore, can be considered indicative of past exposure to the virus. Altogether, the individual ELISAs proved to be as specific and at least as sensitive for the diagnosis of IM as the currently available standard techniques are. Moreover, our findings suggest that, by combining individual test antigens, a workable ELISA system consisting of three assays (IgM against p54, p138, and p150; IgG against p54 and p138; and IgG against p72) can be established for the standardized rapid diagnosis of acute EBV infections.

This article has been cited by other articles:

• Buljevac, D, van Doornum, G J J, Flach, H Z, Groen, J, Osterhaus, A D M E, Hop, W, van Doorn, P A, van der Meche, F G A, Hintzen, R Q (2005). Epstein-Barr virus and disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 76: 1377-1381 [Abstract] [Full Text]  
• Jabs, W. J., Wagner, H. J., Maurmann, S., Hennig, H., Kreft, B. (2002). Inhibition of macrophage inflammatory protein-1alpha production by Epstein-Barr virus. Blood 99: 1512-1516 [Abstract] [Full Text]  
• Lang, D., Vornhagen, R., Rothe, M., Hinderer, W., Sonneborn, H.-H., Plachter, B. (2001). Cross-Reactivity of Epstein-Barr Virus-Specific Immunoglobulin M Antibodies with Cytomegalovirus Antigens Containing Glycine Homopolymers. CVI 8: 747-756 [Abstract] [Full Text]  
• Gomez, M. C., Nieto, J. A., Escribano, M. A. (2000). Evaluation of Two Slide Agglutination Tests and a Novel Immunochromatographic Assay for Rapid Diagnosis of Infectious Mononucleosis. CVI 7: 840-841 [Abstract] [Full Text]  
• Hinderer, W., Lang, D., Rothe, M., Vornhagen, R., Sonneborn, H. H., Wolf, H. (1999). Serodiagnosis of Epstein-Barr Virus Infection by Using Recombinant Viral Capsid Antigen Fragments and Autologous Gene Fusion. J. Clin. Microbiol. 37: 3239-3244 [Abstract] [Full Text]  
• Buisson, M., Fleurent, B., Mak, M., Morand, P., Chan, L., Ng, A., Guan, M., Chin, D., Seigneurin, J. M. (1999). Novel Immunoblot Assay Using Four Recombinant Antigens for Diagnosis of Epstein-Barr Virus Primary Infection and Reactivation. J. Clin. Microbiol. 37: 2709-2714 [Abstract] [Full Text]